ClinicalTrials.gg
Not yet recruitingNCT05890066Updated Jun 7, 2023

Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy

An interventional study of single-port laparoscopy in Ectopic Pregnancy, sponsored by Hung Vuong Hospital. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-07.

Sponsored by Hung Vuong Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study aims to compare the effectiveness and Safety of Single-port Versus Multi-port Laparoscopic Surgery in the Treatment of Ectopic Pregnancy

Read the detailed description

Single-port laparoscopic surgery has become one of the treatment options for ectopic pregnancy with certain advantages such as reduced numbers of incision and scars, and increased patient's satisfaction post-surgery. At Hung Vuong hospital, the investigators do not have data about the application potential of single-port laparoscopic surgery for ectopic pregnancy treatment. Therefore, the investigators carry out this project to compare the effectiveness and safety of single-port versus traditional multi-port laparoscopic surgery in the treatment of ectopic pregnancy.

02

Conditions studied

  • Ectopic Pregnancy

Browse trials for

Keywords

  • Laparoscopic surgery
  • Single-port laparoscope
  • Multi-port laparoscope
03

In context

Pregnancy, Ectopic

83 studies on the registry are indexed under Pregnancy, Ectopic; 21 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 43 interventional studies indexed under Pregnancy, Ectopic.

Browse Pregnancy, Ectopic studies →

Lead sponsor

Hung Vuong Hospital is the lead sponsor of 10 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years old or older pregnant women who are indicated for laparoscopic surgery in the treatment of ectopic pregnancy.
  • Agree to participate and give a consent

Exclusion criteria

Exclusion Criteria:

  • Allergic reactions to anesthetics
  • Hemodynamic instability
  • Ruptured ectopic pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • No intervention
    4-port laparoscopic surgery

    Patients with ectopic pregnancy will receive 4-Port laparoscopic surgery

  • Experimental
    1-port laparoscopic surgery

    Patients with ectopic pregnancy will receive 1-port laparoscopic surgery

    Procedure: single-port laparoscopy

Interventions

  • Proceduresingle-port laparoscopy

    Compare the effectiveness and safety between single-port and multi-port laparoscopic surgery

06

What researchers measure

Primary outcomes

  1. Blood loss

    Measure the amount of blood loss

    Time frame: Immediately post surgery

  2. Surgical time

    How long will it take for single-port vs multi-port surgical procedures

    Time frame: Immediately post surgery

Secondary outcomes

  1. Pain intensity

    Use visual analogue scale to measure

    Time frame: Within 4 weeks post surgery

  2. Surgical complications

    Organ damages, surgical site infections, pneumoperitoneum

    Time frame: Within 4 weeks post surgery

  3. Hospital stay

    How long will be the recovery time

    Time frame: Within 4 weeks post surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2023; primary completion for May 2024, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 25, 2023
First posted
Jun 6, 2023
StartEst.
Nov 1, 2023
Primary completionEst.
May 31, 2024
CompletionEst.
May 31, 2024
Last update
Jun 7, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05890066
Lead sponsor
Hung Vuong Hospital
Responsible party
Tri Bao Nguyen (Principle investigator, Hung Vuong Hospital) — Principal investigator
First posted
Jun 6, 2023
Start date
Nov 1, 2023 (estimated)
Primary completion
May 31, 2024 (estimated)
Completion
May 31, 2024 (estimated)
Last update
Jun 7, 2023

Study contacts

Tri B Nguyen, Doctor
Contact
ngoc.lam@ttu.edu.vn
0983739959
NGOC T LAM, PhD
Contact
Nghiem X Huynh, Doctor
study director · Hung Vuong Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion